VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update

NEXT STORY
L-DOS47 Phase II Randomized Study Advances to Second Cohort
PREV STORY
Biogen To Present Data At AAN Highlighting Its Innovative Marketed Treatments And Investigational Pipeline Programs For Complex Neurodegenerative Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inventiva to host a webcast with Key Opinion Leaders from the AASLD The Liver Meeting™ 2021  

author_avatar
NASDAQ Market News

TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder

author_avatar
NASDAQ Market News

Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

author_avatar
NASDAQ Market News